Perceptive Advisors’s Solid Biosciences SLDB Stock Holding History

Perceptive Advisors’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$119M	Hold	11,906,646	–	–	1.79%	18
2026 Q1	$85.7M	Buy	11,906,646 +73,107	+0.6%	+$470K	1.68%	19
2025 Q4	$66.7M	Hold	11,833,539	–	–	1.19%	28
2025 Q3	$73M	Sell	11,833,539 -73,107	-0.6%	-$427K	2.11%	16
2025 Q2	$58M	Hold	11,906,646	–	–	2.15%	11
2025 Q1	$44.1M	Buy	11,906,646 +5,000,000	+72%	+$21.4M	1.56%	15
2024 Q4	$27.6M	Hold	6,906,646	–	–	0.76%	36
2024 Q3	$48.1M	Hold	6,906,646	–	–	1.02%	31
2024 Q2	$39.2M	Hold	6,906,646	–	–	0.94%	27
2024 Q1	$92M	Buy	6,906,646 +3,410,713	+98%	+$31.9M	1.61%	19
2023 Q4	$21.5M	Hold	3,495,933	–	–	0.48%	51
2023 Q3	$8.81M	Hold	3,495,933	–	–	0.29%	61
2023 Q2	$18.3M	Hold	3,495,933	–	–	0.53%	52
2023 Q1	$16.6M	Hold	3,495,933	–	–	0.49%	48
2022 Q4	$18.8M	Buy	3,495,933 +2,601,763	+291%	+$17.1M	0.53%	46
2022 Q3	$6.26M	Hold	894,170	–	–	0.18%	76
2022 Q2	$8.26M	Hold	894,170	–	–	0.26%	67
2022 Q1	$16.1M	Hold	894,170	–	–	0.32%	64
2021 Q4	$23.5M	Hold	894,170	–	–	0.36%	64
2021 Q3	$32.1M	Hold	894,170	–	–	0.47%	54
2021 Q2	$49.1M	Hold	894,170	–	–	0.64%	42
2021 Q1	$74.2M	Buy	894,170 +173,913	+24%	+$19.2M	0.94%	28
2020 Q4	$81.9M	Buy	720,257 +270,270	+60%	+$17.1M	0.88%	33
2020 Q3	$13.7M	Hold	449,987	–	–	0.2%	77
2020 Q2	$19.8M	Buy	+449,987	New	+$18.7M	0.32%	62
2019 Q4	–	Sell	-449,987	Closed	-$69.8M	–	122
2019 Q3	$69.8M	Buy	449,987 +188,172	+72%	+$21.3M	1.88%	14
2019 Q2	$22.6M	Buy	+261,815	New	+$28.6M	0.52%	45
2019 Q1	–	Sell	-261,815	Closed	-$105M	–	118
2018 Q4	$105M	Buy	+261,815	New	+$123M	4.01%	6

Other funds holding SLDB

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Perceptive Advisors's SLDB Position: Q2 2026 in Review

Perceptive Advisors held its Solid Biosciences (SLDB) position steady in Q2 2026 at 11,906,646 shares worth $119M. The position accounts for 1.79% of the portfolio, ranked #18.

Perceptive Advisors first reported a position in SLDB in Q4 2018 and has held it in 28 quarters since. 156 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

Perceptive Advisors held 11,906,646 shares of Solid Biosciences worth $119M as of Q2 2026.
Perceptive Advisors left its Solid Biosciences share count unchanged in Q2 2026.
Solid Biosciences made up 1.79% of Perceptive Advisors's portfolio in Q2 2026, its #18 holding.
Perceptive Advisors first reported a position in Solid Biosciences in Q4 2018 and has held it in 28 quarters since.
156 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.